 |
Finsbury is handling press for Reckitt Benckiser Group, which yanked its $20B deal on March 21 to acquire Pfizer's consumer healthcare business.
CEO Rakesh Kapoor decided that Pfizer's consumer health business wasn't a good fit, opting instead to concentrate on the $16B integration of Mead Johnson's nutritional formula business and the reorganizing of operations into health and hygiene business units.
GlaxoSmithKline today said it also has decided not to pursue the acquisition of Pfizer's consumer healthcare unit.
“While we will continue to review opportunities that may accelerate our strategy, they must meet our criteria for returns and not compromise our priorities for capital allocation,” said CEO Emma Walmsley in a statement.
Pfizer is reviewing its strategic alternatives, which could mean sale, spin-off or retaining the consumer operation.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Kekst CNC represents Grant Thornton as it sells a majority stake in its US arm to New Mountain Capital, which relies on Goldin Solutions, in what is billed as the largest PE investment in the accounting and advisory sector.
Have a comment? Send it to 
No comments have been submitted for this story yet.